BDNF and myeloid sarcoma: From a clinical perspective the difference of serum BDNF – although significant at the group level – is relatively small and frequent overlap exists between BDNF values in pwMS and HC at the individual level, further limiting the value of BDNF levels as an aid to diagnosis or as a prognostic marker for patients with MS.